Fujimasa Tada

1.5k total citations
36 papers, 564 citations indexed

About

Fujimasa Tada is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Fujimasa Tada has authored 36 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Fujimasa Tada's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (9 papers) and Hepatitis C virus research (9 papers). Fujimasa Tada is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (9 papers) and Hepatitis C virus research (9 papers). Fujimasa Tada collaborates with scholars based in Japan, United States and Vietnam. Fujimasa Tada's co-authors include Yoichi Hiasa, Masanori Abe, Masashi Hirooka, Morikazu Onji, Teruki Miyake, Yoshio Tokumoto, Bunzo Matsuura, Yohei Koizumi, Shinya Furukawa and Hironori Ochi and has published in prestigious journals such as Hepatology, Radiology and Journal of Hepatology.

In The Last Decade

Fujimasa Tada

31 papers receiving 555 citations

Peers

Countries citing papers authored by Fujimasa Tada

Since Specialization

Citations

This map shows the geographic impact of Fujimasa Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujimasa Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujimasa Tada more than expected).

Fields of papers citing papers by Fujimasa Tada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujimasa Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujimasa Tada. The network helps show where Fujimasa Tada may publish in the future.

Co-authorship network of co-authors of Fujimasa Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Fujimasa Tada. A scholar is included among the top collaborators of Fujimasa Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujimasa Tada. Fujimasa Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mirikizumab Efficacy in Ulcerative Colitis: Association With Pretreatment Geboes Score Features in a Case Series 2025 ·Inflammatory Bowel Diseases ·Shogo Kitahata, (unknown), Yuka Kimura, Ayaka Nakamura, Toru Usui, (unknown), (unknown), (unknown), Tomoe Kawamura, Hideko Ohama, Taira Kuroda, Junko Matsuoka, Fujimasa Tada, Hideki Miyata, Atsushi Hiraoka, Eiji Tsubouchi, Tomoyuki Ninomiya, Yoichi Hiasa	0
2	Relationship between Daily Physical Activity and Muscle Cramping in Elderly Liver Cirrhosis Patients: A Multicenter Study 2025 ·Internal Medicine ·Atsushi Hiraoka, Tadashi Namisaki, Masato Nakai, Nagisa Hara, (unknown), Yuichiro Eguchi, Hideko Ohama, Fujimasa Tada, Naoya Sakamoto, Hitoshi Yoshiji	0
3	Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy 2025 ·Oncology ·(unknown), Kosuke Matsui, Hisashi Kosaka, Hideyuki Matsushima, Hidekazu Yamamoto, (unknown), (unknown), Masahiko Takada, Fujimasa Tada, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, (unknown), Kengo Yoshii, Takashi Yamaguchi, Shinji Shimoda, Makoto Naganuma, (unknown)	0
4	Comparison of Surgical Resection and Radiofrequency Ablation for Early‐Stage HCC Patients With Child–Pugh Class B 2025 ·Journal of Gastroenterology and Hepatology ·Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Kazuya Kariyama, Ei Itobayashi, (unknown), Toru Ishikawa, Hidenori Toyoda, (unknown), Atsushi Naganuma, (unknown), Kazunari Tanaka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Shinichiro Nakamura, (unknown), (unknown)	0
5	mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response 2024 ·Journal of Gastroenterology and Hepatology ·Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Kazuya Kariyama, Satoshi Yasuda, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Tomomitsu Matono, Shinichiro Nakamura, Hidenori Toyoda, (unknown)	2
6	Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations 2024 ·Hepatology Research ·Nagisa Hara, Atsushi Hiraoka, Masato Nakai, Makoto Shiraki, Tadashi Namisaki, Hisamitsu Miyaaki, (unknown), Hirokazu Takahashi, Hideko Ohama, Fujimasa Tada, Naoya Sakamoto, Kazuhiko Nakao, Taro Takami, Yuichiro Eguchi, Hitoshi Yoshiji	2
7	Clinical role of radiofrequency ablation for early‐stage hepatocellular carcinoma in an advanced aging society 2023 ·Hepatology Research ·Hironori Ochi, Atsushi Hiraoka, Takaaki Tanaka, Toshie Mashiba, Hideko Ohama, Fujimasa Tada, (unknown), (unknown), (unknown), (unknown), Masashi Hirooka, Tomoyuki Yokota, Yoichi Hiasa	2
8	Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era 2023 ·Cancers ·(unknown), Masashi Hirooka, Atsushi Hiraoka, Yohei Koizumi, (unknown), (unknown), (unknown), Yusuke Imai, Hideko Ohama, (unknown), Takao Watanabe, Fujimasa Tada, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa	7
9	Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test 2022 ·Hepatology Research ·Atsushi Hiraoka, Masato Nakai, Nagisa Hara, Tatsunori Hanai, Tadashi Namisaki, Hisamitsu Miyaaki, Takashi Nakahara, Akira Hiramatsu, Hideko Ohama, Fujimasa Tada, Hirokazu Takahashi, Hiroshi Aikata, Yuichiro Eguchi, Yoichi Hiasa, Hitoshi Yoshiji	3
10	Pancreas stiffness in liver cirrhosis is an indicator of insulin secretion caused by portal hypertension and pancreatic congestion 2021 ·Hepatology Research ·Yoshiki Imamura, Teru Kumagi, Taira Kuroda, Mitsuhito Koizumi, Osamu Yoshida, (unknown), Fujimasa Tada, Yoshinori Tanaka, Masashi Hirooka, Yoichi Hiasa	9
11	AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy 2021 ·BMC Cancer ·Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Fujimasa Tada, Yoshiyasu Kisaka, Seiji Nakanishi, Kazuhiko Yamauchi, Hironori Ochi, Atsushi Hiraoka, (unknown), Atsushi Yukimoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa	14
12	Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection 2020 ·Journal of Medical Virology ·Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Fujimasa Tada, Yoshiyasu Kisaka, Seiji Nakanishi, Kazuhiko Yamauchi, Atsushi Yukimoto, Yoshiko Nakamura, Masashi Hirooka, Masanori Abe, Yoichi Hiasa	6
13	Predictors of hepatocellular carcinoma occurrence after direct‐acting antiviral therapy in patients with hepatitis C virus infection 2018 ·Hepatology Research ·Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Fujimasa Tada, Yoshiyasu Kisaka, Seiji Nakanishi, Kazuhiko Yamauchi, Atsushi Yukimoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa	45
14	Nonalcoholic Fatty Liver Disease: Portal Hypertension Due to Outflow Block in Patients without Cirrhosis 2014 ·Radiology ·Masashi Hirooka, Yohei Koizumi, Teruki Miyake, Hironori Ochi, Yoshio Tokumoto, Fujimasa Tada, Bunzo Matsuura, Masanori Abe, Yoichi Hiasa	26
15	Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity 2013 ·Laboratory Investigation ·Keitarou Kawasaki, Masanori Abe, Fujimasa Tada, Yoshio Tokumoto, Shiyi Chen, Teruki Miyake, Shinya Furukawa, Bunzo Matsuura, Yoichi Hiasa, Morikazu Onji	27
16	B cell activating factor in obesity is regulated by oxidative stress in adipocytes 2013 ·Journal of Clinical Biochemistry and Nutrition ·Fujimasa Tada, Masanori Abe, Keitarou Kawasaki, Teruki Miyake, Shiyi Chen, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji	15
17	Hepatocellular carcinoma in a chronic hepatitis C patient 15 years after achieving a sustained virological response 2012 ·Kanzo ·(unknown), Yohei Koizumi, Masashi Hirooka, Hironori Ochi, Fujimasa Tada, Toru Ishihara, Yoshio Tokumoto, Masanori Abe, Yoshikuni Yonenaga, Taiji Tohyama, Yasutsugu Takada, Yoichi Hiasa, Morikazu Onji	4
18	B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease 2012 ·Hepatology International ·Teruki Miyake, Masanori Abe, Yoshio Tokumoto, Masashi Hirooka, Shinya Furukawa, Teru Kumagi, (unknown), Keitarou Kawasaki, Fujimasa Tada, Teruhisa Ueda, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji	51
19	Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases 2012 ·Hepatology ·Hironori Ochi, Masashi Hirooka, Yohei Koizumi, Teruki Miyake, Yoshio Tokumoto, (unknown), Fujimasa Tada, Masanori Abe, Yoichi Hiasa, Morikazu Onji	87
20	Thrombosis of the Left Brachiocephalic Vein After Subtotal Esophagectomy with Reconstruction Using a Retrosternally Shifted Gastric Tube: Report of a Case 2007 ·Surgery Today ·Masato Maeda, Toshihiko Goto, Eiji Yamamura, (unknown), Fujimasa Tada, Masayuki Nakau, (unknown), Tadashi Miyashita	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact